Westshore Wealth, LLC Gilead Sciences, Inc. Transaction History

Westshore Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $305,354 - $382,641	-5,272 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$64.88 - $73.64 $19,464 - $22,092	-300 Reduced 5.38%	5,272 $383,000
Q3 2021 Nov 16, 2021	SELL	$67.69 - $73.03 $185,876 - $200,540	-2,746 Reduced 33.01%	5,572 $389,000
Q2 2021 Aug 19, 2021	BUY	$63.47 - $69.35 $6,347 - $6,934	100 Added 1.22%	8,318 $573,000
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $197,160 - $224,959	3,286 Added 66.63%	8,218 $531,000
Q4 2019 Mar 30, 2020	BUY	$61.62 - $67.78 $303,909 - $334,290	4,932 New	4,932 $320,000

1,925

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Westshore Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Westshore Wealth, LLC with notifications on news.